Esteemed Colleagues, Dear Friends,
It is with great honor and a profound sense of responsibility that I assume the role of President of the Cell Transplant and Regenerative Medicine Society (CTRMS). I am deeply grateful for the confidence you have placed in me and for the opportunity to serve this distinguished community of scientists, clinicians, and innovators.
I would like to express our deepest gratitude to the councilors who have served CTRMS in the past and have rotated out in Tokyo, and the appreciation for the many people who made the 2025 Congress in Tokyo such a great success.
CTRMS occupies a unique position at the intersection of transplantation and regenerative medicine. Though distinct, these disciplines share a common lineage in Alexis Carrel and a unified purpose: advancing therapies that restore function and transform patient outcomes. Over the past several years, we have observed both extraordinary progress and persistent gaps in collaboration between these fields. Our foremost objective during this presidency is to strengthen these connections, fostering an integrated approach that accelerates scientific discovery and clinical translation.
CTRMS will focus on the following priorities:
We will achieve this vision through:
I therefore invite you to take an active part in shaping the future of CTRMS. Here are immediate steps you can take:
I am pleased to announce that planning for the 2027 CTRMS Congress is underway. This landmark event will be hosted at a venue emblematic of our commitment to excellence and global impact. More to come.
Together, we can ensure that CTRMS remains at the forefront of innovation and continues to deliver transformative solutions for patients worldwide.
Thank you for your dedication and support. I look forward to working with each of you in advancing the mission of CTRMS.
With highest regards,
Giuseppe Orlando, MD, PhD, Marie Curie Fellow
President, CTRMS
Happy New Year! As we embark on this exciting journey into 2025, I am honored to greet you on behalf of the Cell Transplant and Regenerative Medicine Society (CTRMS). This year marks a fresh chapter for us as we strengthen our commitment to advancing cell transplantation and regenerative medicine through collaboration, innovation, and knowledge-sharing.
With the start of the new year, I am thrilled to introduce CellTx NexT, our quarterly newsletter dedicated to keeping you connected with the latest from CTRMS and our dynamic field. Each edition will feature updates on society initiatives, cutting-edge research highlights, details of upcoming events, and inspiring breakthroughs that shape the future of cell transplantation and regenerative medicine.
This initiative aligns seamlessly with CTRMS’s newly refined mission, goals, and vision. Our revised mission emphasizes the pursuit of transformative science and global collaboration to improve outcomes for patients worldwide. The goals of CTRMS have been sharpened to foster innovation, support education, and facilitate meaningful connections among researchers, clinicians, and industry leaders. Our vision remains steadfast: to lead the world in driving scientific advancements and creating real-world impacts for regenerative medicine.
We are also proud to share that our society has revitalized its social media presence, making it easier than ever to stay informed and engaged. I invite all members to connect with us on these channels to stay up-to-date and participate in ongoing conversations shaping our field.
As CTRMS continues to grow, your involvement is vital. Your contributions and insights shape the heart of this society, and I am confident that together, we will achieve remarkable milestones this year.
Thank you for your dedication to advancing our shared vision. I look forward to the discoveries, connections, and innovations that lie ahead.
Toshio Miki, MD, PhD
Past-President, CTRMS
Cell Transplant and Regenerative Medicine Society
c/o The Transplantation Society
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada